Search results
Results from the WOW.Com Content Network
VC firms flocked to the biotech industry with the onset of the p. Editor's Note: This article is part of our series marking the second anniversary of the pandemic. Other installments include ...
Alnylam (ALNY): pioneering a new class of therapeutics based on RNA interference and a better fit for collaboration partner Novartis (NYSE:NVS) BioMarin (NASDAQ:BMRN): a rare disease gene therapy ...
Infrastructure, robotics, biotech Silicene: Early research Nanoscale electronics Superalloy: Research, diffusion Significantly stronger metal components (particularly in aircraft jet engines) Synthetic diamond: Research, commercialization Electronics Time crystal: Research experiments [86] Quantum computers with stable qubits: Translucent concrete
They're both innovative biotechs working in relatively newer niches of this booming industry. However, they've moved in the wrong direction this year. CRISPR's shares are down by 27% year to date ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The growing use of mass spectrometry, especially in the life sciences sector, which includes pharmaceutical production, biotechnology, and other fields; the rising demand for new and improved instruments and equipment from end-users around the world; the growing emphasis on R&D in the healthcare industry, which has led to an increase in R&D ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Biotech stocks have a reputation as a high-risk investment. However, a bear market represents a good time to take a chance on these biotech stocks.